2012•Chinese Journal of Clinical PharmacyRequires access

Pharmacokinetic characteristics of sodium rabeprazole in humans

LU Hui-qin

Open publisher page 0 citations

Abstract

AIM To study the pharmacokinetics of sodium rabeprazole injection in humans.METHODS Thirty healthy volunteers were randomly divided into 3 groups who received the sodium rabeprazole injection,and the doses were 10 mg,20 mg and 30 mg,respectively.Each volunteer's blood samples were collected in 8 h after the injection.The 20 mg group' s volunteers were given multiply dose subsequently when the first dose tests were finished and the blood samples were collected.LC-MS/MS was used to determine plasma concentrations of rabeprazole and pharmacokinetic parameters were calculated by DAS software.RESULTS The main pharmacokinetic parameters of rabeprazole in the 10 mg,20 mg and 40 mg groups were as Mows:ρ_(max)were(699.89±198.89),(1 274.82±272.99)and(2 572.00±640.57)μg·L~(-1);t_(max)were(0.53±0.09),(0.43±0.09)and(0.52±0.09)h;t_(1/2)were(1.34±0.47),(0.97±0.29)and (1.43±0.39)h;AUC_(0→8)were(864.23±369.13),(1 477.88±311.65)and(3 444.86±1 175.38)μg·h·L~(-1); AUC_(0→∞)were(877.16±379.48),(1 484.05±313.24)and(3 501.05±1 236.70)μg·h·L~(-1),respectively.The main pharmacokinetic parameters of 20 mg group were as follows:ρ_(max)~(ss)was(1 299.50±290.20)μg·L~(-1);t_(max)was (0.53±0.10)h;t_(1/2)was(0.89±0.29)h;AUC_(0→8)~(ss)was(1 447.08±421.03)μg·h·L~(-1);AUC_(0→∞)~(ss)was (1 454.19±420.65)μg·h·L~(-1);DF was(22.58±5.50)%.CONCLUSION Sodium rabeprazole injection showes well linear pharmacokinetic characteristics in human body when the doses range from 10 mg to 40 mg.

About this research paper

What this paper is about

AIM To study the pharmacokinetics of sodium rabeprazole injection in humans.METHODS Thirty healthy volunteers were randomly divided into 3 groups who received the sodium rabeprazole injection,and the doses were 10 mg,20 mg and 30 mg,respectively.Each volunteer's blood samples were collected in 8 h after the injection.The 20 mg group' s volunteers were given multiply dose subsequently when the first dose tests were finished and the blood samples were collected.LC-MS/MS was used to determine plasma concentrations of rabeprazole and pharmacokinetic parameters were calculated by DAS software.RESULTS The main pharmacokinetic parameters of rabeprazole in the 10 mg,20 mg and 40 mg groups were as Mows:ρ_(max)were(699.89±198.89),(1 274.82±272.99)and(2 572.00±640.57)μg·L~(-1);t_(max)were(0.53±0.09),(0.43±0.09)and(0.52±0.09)h;t_(1/2)were(1.34±0.47),(0.97±0.29)and (1.43±0.39)h;AUC_(0→8)were(864.23±369.13),(1 477.88±311.65)and(3 444.86±1 175.38)μg·h·L~(-1); AUC_(0→∞)were(877.16±379.48),(1 484.05±313.24)and(3 501.05±1 236.70)μg·h·L~(-1),respectively.The main pharmacokinetic parameters of 20 mg group were as follows:ρ_(max)~(ss)was(1 299.50±290.20)μg·L~(-1);t_(max)was (0.53±0.10)h;t_(1/2)was(0.89±0.29)h;AUC_(0→8)~(ss)was(1 447.08±421.03)μg·h·L~(-1);AUC_(0→∞)~(ss)was (1 454.19±420.65)μg·h·L~(-1);DF was(22.58±5.50)%.CONCLUSION Sodium rabeprazole injection showes well linear pharmacokinetic characteristics in human body when the doses range from 10 mg to 40 mg.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM To study the pharmacokinetics of sodium rabeprazole injection in humans.METHODS Thirty healthy volunteers were randomly divided into 3 groups who received the sodium rabeprazole injection,and the doses were 10 mg,20 mg and 30 mg,respectively.Each volunteer's blood samples were collected in 8 h after the injection.The 20 mg group' s volunteers were given multiply dose subsequently when the first dose tests were finished and the blood samples were collected.LC-MS/MS was used to determine plasma concentrations of rabeprazole and pharmacokinetic parameters were calculated by DAS software.RESULTS The main pharmacokinetic parameters of rabeprazole in the 10 mg,20 mg and 40 mg groups were as Mows:ρ_(max)were(699.89±198.89),(1 274.82±272.99)and(2 572.00±640.57)μg·L~(-1);t_(max)were(0.53±0.09),(0.43±0.09)and(0.52±0.09)h;t_(1/2)were(1.34±0.47),(0.97±0.29)and (1.43±0.39)h;AUC_(0→8)were(864.23±369.13),(1 477.88±311.65)and(3 444.86±1 175.38)μg·h·L~(-1); AUC_(0→∞)were(877.16±379.48),(1 484.05±313.24)and(3 501.05±1 236.70)μg·h·L~(-1),respectively.The main pharmacokinetic parameters of 20 mg group were as follows:ρ_(max)~(ss)was(1 299.50±290.20)μg·L~(-1);t_(max)was (0.53±0.10)h;t_(1/2)was(0.89±0.29)h;AUC_(0→8)~(ss)was(1 447.08±421.03)μg·h·L~(-1);AUC_(0→∞)~(ss)was (1 454.19±420.65)μg·h·L~(-1);DF was(22.58±5.50)%.CONCLUSION Sodium rabeprazole injection showes well linear pharmacokinetic characteristics in human body when the doses range from 10 mg to 40 mg.

Key concepts: Pharmacokinetics, Volunteer, Rabeprazole, Chemistry, Sodium, Pharmacology, Chromatography, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetic characteristics of sodium rabeprazole in humans — Research Paper | ScholarLens